Preclinical data reinforces potential efficacy, durability of investigational gene therapy for DMD – News-Medical.net
News-Medical.net |
Preclinical data reinforces potential efficacy, durability of investigational gene therapy for DMD
News-Medical.net Solid Biosciences announced today that new data from two preclinical studies reinforce the potential of its investigational microdystrophin gene therapy, SGT-001, to be an effective treatment approach for Duchenne muscular dystrophy (DMD). The … |
